MFAP3
Microfibril-associated glycoprotein 3
Also known as: MFAP3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55082
- Gene
- MFAP3
- Ensembl
- ENSG00000037749
- Chromosome
- 5
- Canonical length
- 362 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>P55082|MFAP3
1 MKLHCCLFTL VASIIVPAAF VLEDVDFDQM VSLEANRSSY NASFPSSFEL SASSHSDDDV
61 IIAKEGTSVS IECLLTASHY EDVHWHNSKG QQLDGRSRGG KWLVSDNFLN ITNVAFDDRG
121 LYTCFVTSPI RASYSVTLRV IFTSGDMSVY YMIVCLIAFT ITLILNVTRL CMMSSHLRKT
181 EKAINEFFRT EGAEKLQKAF EIAKRIPIIT SAKTLELAKV TQFKTMEFAR YIEELARSVP
241 LPPLILNCRA FVEEMFEAVR VDDPDDLGER IKERPALNAQ GGIYVINPEM GRSNSPGGDS
301 DDGSLNEQGQ EIAVQVSVHL QSETKSIDTE SQGSSHFSPP DDIGSAESNC NYKDGAYENC
361 QLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFAP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 23 nTPM
- placenta: 18 nTPM
- tongue: 16 nTPM
- smooth muscle: 16 nTPM
- urinary bladder: 15 nTPM
- adipose tissue: 15 nTPM
Single-cell type
- myonuclei: 61 nCPM
- tuft cells: 58 nCPM
- astrocytes: 55 nCPM
- brain inhibitory neurons: 52 nCPM
- müller glia: 52 nCPM
- brain excitatory neurons: 51 nCPM
Immune cell
- eosinophil: 12 nTPM
- myeloid DC: 8.1 nTPM
- intermediate monocyte: 7.9 nTPM
- classical monocyte: 7.6 nTPM
- MAIT T-cell: 6.9 nTPM
- basophil: 6.8 nTPM
Brain region
- choroid plexus: 24 nTPM
- cerebellum: 20 nTPM
- spinal cord: 17 nTPM
- cerebral cortex: 16 nTPM
- hypothalamus: 16 nTPM
- pons: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFAP3 as an antibody target. Whether an autoantibody or antibody against MFAP3 could matter depends on whether native MFAP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFAP3 is annotated at the cell surface, where native MFAP3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MFAP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...